We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. District Court in Boston has ruled that a Dana-Farber Cancer Institute scientist and a former member of the Genetics Institute deserve credit as co-inventors of six valuable cancer immunotherapy patents. Read More
A key House subcommittee will take its turn grilling the drug industry Tuesday as it considers seven separate pieces of legislation that backers say would help reduce spiraling drug prices. Read More
Federal judges—and not juries—should say what constitutes “clear evidence” that the FDA would likely have rejected changes to a drug’s label, the Supreme Court ruled Monday in a decision that could have far-reaching impact on preemption cases. Read More
Oklahoma AG Mike Hunter is claiming that the drug companies’ opioid business constitutes a public nuisance and is demanding millions in damages. Read More
The World Health Organization released draft guidelines advising regulators to test the wastewater of drug plants to keep antibiotics out of the environment—and it says wastewater treatment should be part of good manufacturing practices. Read More